1 Ross University School of Medicine, Barbados.
2 University of South Florida, Tampa, FL, USA.
3 American University of the Caribbean, AUC, St. Maarten.
4 Memorial Healthcare System, Pembroke Pines, FL, USA.
5 Research Writing & Publication (RWP), LLC, NY, USA.
World Journal of Biology Pharmacy and Health Sciences, 2026, 27(01), 167–171
Article DOI: 10.30574/wjbphs.2026.27.1.0398
Received on 14 June 2026; revised on 19 July 2026; accepted on 22 July 2026
Aggressive angiomyxoma (AAM), is a rare, slow-growing mesenchymal tumor that frequently mimics benign vulvar lesions, leading to delayed or missed diagnosis. We report the case of a 29-year-old woman presenting with a painless, progressively enlarging left vulvar mass. The lesion had been excised two years prior and was presumed to be a benign cyst; however, it gradually recurred over the subsequent months. The patient denied systemic symptoms but reported discomfort with sitting and ambulation. Laboratory findings were unremarkable, and physical examination was inconsistent with a simple cyst, prompting a broader differential diagnosis. Magnetic resonance imaging (MRI) demonstrated a well-circumscribed, lobulated 8×6×2 cm mass with high T2 signal intensity and a characteristic laminated (“swirled”) internal architecture, displacing adjacent structures without evidence of invasion.
Given concern for recurrent AAM, a multidisciplinary team proceeded with wide local excision, achieving negative margins, followed by adjunctive gonadotropin-releasing hormone (GnRH) agonist therapy to reduce the risk of recurrence. Histopathologic evaluation revealed a gelatinous, hypocellular tumor, and immunohistochemical (IHC) findings confirmed the diagnosis of angiomyxoma.
At 18-month follow-up, there was no evidence of recurrence. This case highlights the importance of maintaining a broad differential diagnosis for vulvar masses to avoid misdiagnosis of AAM, as well as the value of a multidisciplinary approach and adjunct hormonal therapy in optimizing patient outcomes.
Aggressive angiomyxoma; Mesenchymal tumor; Gonadotropin-releasing hormone; Recurrence; Hormonal therapy
Get Your e Certificate of Publication using below link
Preview Article PDF
Amanda Herrera, Grace Durham, Imran Shahid, Mohammad Abukhaled, Jessica Jahoda and Mohamed Aziz. Diagnostic pitfalls in vulvar masses: A case report of recurrent aggressive angiomyxoma and a brief review of literature. World Journal of Biology Pharmacy and Health Sciences, 2026, 27(01), 167–171. Article DOI: https://doi.org/10.30574/wjbphs.2026.27.1.0398